--- title: "TD Cowen 維持對 Soleno Therapeutics(SLNO)的買入評級" description: "Van Buren 涉及醫療保健行業,專注於 Soleno Therapeutics、Regeneron 和 Gilead Sciences 等股票。根據 TipRanks 的數據,Van Buren 的平均回報率為 3.9%,推薦股票的成功率為 48.86%。市場普遍認為,分析師對 Soleno Therapeutics 的評級為強烈買入,平均目標價為 119.30 美元,較當前水平有 101." type: "news" locale: "zh-HK" url: "https://longbridge.com/zh-HK/news/260046030.md" published_at: "2025-10-06T11:36:02.000Z" --- # TD Cowen 維持對 Soleno Therapeutics(SLNO)的買入評級 > Van Buren 涉及醫療保健行業,專注於 Soleno Therapeutics、Regeneron 和 Gilead Sciences 等股票。根據 TipRanks 的數據,Van Buren 的平均回報率為 3.9%,推薦股票的成功率為 48.86%。市場普遍認為,分析師對 Soleno Therapeutics 的評級為強烈買入,平均目標價為 119.30 美元,較當前水平有 101.49% 的上漲空間。在 10 月 3 日發佈的一份報告中,Piper Sandler 也對該股票維持了買入評級,目標價為 145.00 美元 Van Buren 涉及醫療保健行業,專注於 Soleno Therapeutics、Regeneron 和 Gilead Sciences 等股票。根據 TipRanks 的數據,Van Buren 推薦股票的平均回報率為 3.9%,成功率為 48.86%。 市場普遍認為,分析師對 Soleno Therapeutics 的評級為強烈買入,平均目標價為 119.30 美元,較當前水平有 101.49% 的上漲空間。在 10 月 3 日發佈的一份報告中,Piper Sandler 也維持了該股票的買入評級,目標價為 145.00 美元。 ### Related Stocks - [SLNO.US - Soleno治療](https://longbridge.com/zh-HK/quote/SLNO.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | A Look At Acadia Healthcare (ACHC) Valuation After David Einhorn Stake And Leadership Changes | Acadia Healthcare (ACHC) gained attention after David Einhorn disclosed a new stake, leading to increased trading volume | [Link](https://longbridge.com/zh-HK/news/275994576.md) | | Where Were The Job Opportunities In 2025? Where Will They Be In 2026? | In 2025, job growth was minimal, with only Education and Health Care (+697,000 jobs) and Leisure and Hospitality (+119,0 | [Link](https://longbridge.com/zh-HK/news/275986113.md) | | Jefferies Reaffirms Their Hold Rating on Novartis AG (NOVN) | Jefferies analyst James Vane has reaffirmed a Hold rating on Novartis AG (NOVN) with a price target of CHF110.00. Vane, | [Link](https://longbridge.com/zh-HK/news/276102881.md) | | ZAWYA-PRESSR: Saudi German Health and Mayo Clinic at World Health Expo (WHX) 2026 | At the World Health Expo 2026, Saudi German Health and Mayo Clinic held a leadership session to discuss collaboration in | [Link](https://longbridge.com/zh-HK/news/275854742.md) | | ICICI Securities Remains a Buy on PNC Infratech Ltd (PNCINFRA) | In a report released today, Mohit Kumar from ICICI Securities maintained a Buy rating on PNC Infratech Ltd, with a price | [Link](https://longbridge.com/zh-HK/news/275801553.md) | --- > **免責聲明**:本文內容僅供參考,不構成任何投資建議。